158 related articles for article (PubMed ID: 3596798)
1. Factors influencing the phagocytosis of Clostridium difficile by human polymorphonuclear leukocytes.
Dailey DC; Kaiser A; Schloemer RH
Infect Immun; 1987 Jul; 55(7):1541-6. PubMed ID: 3596798
[TBL] [Abstract][Full Text] [Related]
2. Trans-10, cis-12 conjugated linoleic acid modulates phagocytic responses of canine peripheral blood polymorphonuclear neutrophilic leukocytes exposed to Clostridium difficile toxin B.
Kang JH; Lee GS; Jeung EB; Yang MP
Vet Immunol Immunopathol; 2009 Aug; 130(3-4):178-86. PubMed ID: 19269037
[TBL] [Abstract][Full Text] [Related]
3. Effect of staphylococcal alpha-toxin on phagocytosis of staphylococci by human polymorphonuclear leukocytes.
Gemmell CG; Peterson PK; Schmeling DJ; Quie PG
Infect Immun; 1982 Dec; 38(3):975-80. PubMed ID: 7152682
[TBL] [Abstract][Full Text] [Related]
4. Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro.
Lima AA; Lyerly DM; Wilkins TD; Innes DJ; Guerrant RL
Infect Immun; 1988 Mar; 56(3):582-8. PubMed ID: 3343050
[TBL] [Abstract][Full Text] [Related]
5. Commercial latex test for Clostridium difficile toxin A does not detect toxin A.
Lyerly DM; Wilkins TD
J Clin Microbiol; 1986 Mar; 23(3):622-3. PubMed ID: 3082928
[TBL] [Abstract][Full Text] [Related]
6. Analysis of latex agglutination test for Clostridium difficile toxin A (D-1) and differentiation between C difficile toxins A and B and latex reactive protein.
Borriello SP; Barclay FE; Reed PJ; Welch AR; Brown JD; Burdon DW
J Clin Pathol; 1987 May; 40(5):573-80. PubMed ID: 3108333
[TBL] [Abstract][Full Text] [Related]
7. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
[TBL] [Abstract][Full Text] [Related]
8. Enzyme immunoassay for detection of antibody to toxins A and B of Clostridium difficile.
Viscidi RP; Yolken RH; Laughon BE; Bartlett JG
J Clin Microbiol; 1983 Aug; 18(2):242-7. PubMed ID: 6619280
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of Clostridium difficile-associated intestinal disease.
Rolfe RD
Crit Rev Clin Lab Sci; 1986; 24(3):235-61. PubMed ID: 3539522
[TBL] [Abstract][Full Text] [Related]
10. The effects of Legionella pneumophila toxin on oxidative processes and bacterial killing of human polymorphonuclear leukocytes.
Friedman RL; Lochner JE; Bigley RH; Iglewski BH
J Infect Dis; 1982 Sep; 146(3):328-34. PubMed ID: 7050255
[TBL] [Abstract][Full Text] [Related]
11. Release of leukotriene B4 from human neutrophils after interaction with nontypeable Haemophilus influenzae.
Garofalo R; Faden H; Sharma S; Ogra PL
Infect Immun; 1991 Nov; 59(11):4221-6. PubMed ID: 1657784
[TBL] [Abstract][Full Text] [Related]
12. Interaction between Clostridium difficile and polymorphonuclear leucocytes from the elderly and post-operative cancer patients: phagocytosis and bactericidal function.
Bassaris HP; Lianou PE; Legakis NJ; Papavassiliou JT
Med Microbiol Immunol; 1984; 173(1):49-55. PubMed ID: 6472200
[TBL] [Abstract][Full Text] [Related]
13. Effects of Clostridium difficile toxin B on human monocytes and macrophages: possible relationship with cytoskeletal rearrangement.
Siffert JC; Baldacini O; Kuhry JG; Wachsmann D; Benabdelmoumene S; Faradji A; Monteil H; Poindron P
Infect Immun; 1993 Mar; 61(3):1082-90. PubMed ID: 8432590
[TBL] [Abstract][Full Text] [Related]
14. Identification of toxigenic Clostridium difficile strains by using a toxin A gene-specific probe.
Wren BW; Clayton CL; Castledine NB; Tabaqchali S
J Clin Microbiol; 1990 Aug; 28(8):1808-12. PubMed ID: 2118549
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of toxigenic Clostridium difficile by nontoxigenic C. difficile.
Wilson KH; Sheagren JN
J Infect Dis; 1983 Apr; 147(4):733-6. PubMed ID: 6842009
[TBL] [Abstract][Full Text] [Related]
16. Serum antibody response to Clostridium difficile toxins in patients with Clostridium difficile diarrhoea.
Aronsson B; Granström M; Möllby R; Nord CE
Infection; 1985; 13(3):97-101. PubMed ID: 4030111
[TBL] [Abstract][Full Text] [Related]
17. Laboratory diagnosis of toxigenic Clostridium difficile by polymerase chain reaction: presence of toxin genes and their stable expression in toxigenic isolates from Japanese individuals.
Karasawa T; Nojiri T; Hayashi Y; Maegawa T; Yamakawa K; Wang XM; Nakamura S
J Gastroenterol; 1999 Feb; 34(1):41-5. PubMed ID: 10204609
[TBL] [Abstract][Full Text] [Related]
18. Identification of toxigenic Clostridium difficile by the polymerase chain reaction.
Kato N; Ou CY; Kato H; Bartley SL; Brown VK; Dowell VR; Ueno K
J Clin Microbiol; 1991 Jan; 29(1):33-7. PubMed ID: 1993763
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile and Clostridium sordellii toxins, proinflammatory versus anti-inflammatory response.
Popoff MR
Toxicon; 2018 Jul; 149():54-64. PubMed ID: 29146177
[TBL] [Abstract][Full Text] [Related]
20. Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters.
Kim PH; Iaconis JP; Rolfe RD
Infect Immun; 1987 Dec; 55(12):2984-92. PubMed ID: 3679541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
